Received by email:
File: Attachment RewardStream Solutions Inc. - EuroMed Therapeutics Ltd. - News Release (Termination).DOCX
REWARDSTREAM TERMINATES TRANSACTION WITH ISRAELI CANNABIS LICENSEE
Vancouver, British Columbia, October 13th, 2019 - RewardStream Solutions Inc. (TSXV: REW and Frankfurt: JL4L, WKN Numb
--->er A2APX1) (the "Company") announces that it has reached an agreement with EuroMed Therapeutics Ltd. ("EuroMed") to te
--->rminate the definitive share purchase agreement (the "Definitive Agreement") entered into between the parties. No fun
--->ds were advanced by the Company to EuroMed, and the Company has not assumed any contingent liabilities or guarantees a
--->rising from the Definitive Agreement. In connection with the termination, EuroMed has agreed to reimburse certain pro
--->fessional fees and due diligence expenses incurred by the Company.
Following termination of the Definitive Agreement, the Company no longer has any active operations and will not meet t
--->he continued listing requirements of the TSX Venture Exchange (the "Exchange"). While the Company intends to apply fo
--->r the reinstatement of trading in its common shares on the Exchange, it is anticipated that Company's listing will be
--->transferred to the NEX board of the Exchange. Transfer to the NEX board is subject to meeting applicable listing requi
--->rements of the Exchange.
For more information contact:
Patrick Morris, Chief Executive Officer
enermetalventures@gmail.com or 604-283-1722
Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the
--->TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forw
--->ard-looking statements include, but are not limited to, statements with respect to the reinstatement of trading on the
---> TSX Venture Exchange. Forward-looking statements are necessarily based upon a number of estimates and assumptions tha
--->t, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cau
--->se the actual results and future events to differ materially from those expressed or implied by such forward-looking s
--->tatements. Such factors include, but are not limited to: general business, economic, competitive, political and social
---> uncertainties, uncertain capital markets; and delay or failure to receive regulatory approvals. There can be no assur
--->ance that trading will be reinstated on the terms set forth above, and actual results and future events could differ m
--->aterially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-l
--->ooking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statement
--->s, whether as a result of new information, future events or otherwise, except as required by law.
© 2026 Canjex Publishing Ltd. All rights reserved.